BRCA2‐positive lung adenocarcinoma treated with olaparib: A case report

BRCA2‐positive lung adenocarcinoma treated with olaparib: A case report

Abstract A 66‐year‐old woman was found to have abnormal shadows on a chest radiograph at a previous hospital 4 years ago, which led to a diagnosis of lung adenocarcinoma, cT2aN1M1b stage IVA. First‐line treatment included carboplatin and paclitaxel plus thoracic radiotherapy and stereotactic radiati...

Full description

Bibliographic Details
Main Authors: Takumi Motohashi, Kazutoshi Isobe, Takahiro Yoshizawa, Yusuke Usui, Hiroshige Shimizu, Muneyuki Sekiya, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Susumu Sakamoto, Sakae Homma, Sota Sadamoto, Naobumi Tochigi, Kazuma Kishi
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Respirology Case Reports
Subjects:
adenocarcinoma
BRCA2 gene mutation
cancer genomic profiling test
olaparib
Online Access:https://doi.org/10.1002/rcr2.1317

Internet

https://doi.org/10.1002/rcr2.1317

Similar Items